Metraipolis › archive › dc_be08045840e0

Roles of Restricted Mean Survival Time and Restricted Mean Time Lost in Evaluating Immune Checkpoint Inhibitor Efficacy for Extensive-Stage Small Cell Lung… — Europe PMC PMID:41334888

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41334888
DOI: 10.1158/2767-9764.crc-25-0387
License (as archived): solo-consultazione
Archived: 2026-11-07T04:42:32.148Z
SHA-256 of the archived text: c639d4e61f6a96dd4335bee89942626774a9f909e505ce0737e985c3db2d3847
Stable URL of this page: https://metraipolis.com/documento/dc_be08045840e0

How to cite

Roles of Restricted Mean Survival Time and Restricted Mean Time Lost in Evaluating Immune Checkpoint Inhibitor Efficacy for Extensive-Stage Small Cell Lung… — Europe PMC PMID:41334888 — Europe PMC (en), https://europepmc.org/article/MED/41334888 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be08045840e0 (Metraipolis archive dc_be08045840e0, sha256 c639d4e61f6a96dd4335bee89942626774a9f909e505ce0737e985c3db2d3847)

BibTeX

@misc{dcbe08045840e0,
  title = {Roles of Restricted Mean Survival Time and Restricted Mean Time Lost in Evaluating Immune Checkpoint Inhibitor Efficacy for Extensive-Stage Small Cell Lung… — Europe PMC PMID:41334888},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41334888},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be08045840e0; sha256 c639d4e61f6a96dd4335bee89942626774a9f909e505ce0737e985c3db2d3847},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41334888. Agents can read the archived copy with the MCP tool read_document.